Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care

Authors:

Abstract
Chronic kidney disease (CKD) is a large and growing concern in the United States, with an estimated prevalence of 15%.1 In 2012, the Medicare cost for CKD treatment was $87 billion, with $28.6 billion for dialysis treatment.2,3 Chronic kidney disease is associated with a 5-year all-cause mortality rate of 24.3% for stage 3 and 45.7% for stage 4 and a 5-year need for renal replacement of 1.3% for stage 3 and 19.9% for stage 4.4

This publication has 25 references indexed in Scilit: